Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.7k Views
Ono & Opdivo: Is the Backlash Orchestrated?
The announcement by the Japan Society of Medical Oncology (JSMO) urging patients to take caution over usage of immune checkpoint inhibitors, such...
321 Views
Volatile earnings with distant prospects of growth
Sosei Group plans to raise US$78m through an issuance of primary shares. We would be inclined to avoid the deal, given: 1) Proceeds from the share...
391 Views